Current research in translational medicine
Nanoparticle albumin-bound paclitaxel (nab-Paclitaxel): Bridging pharmacology and translational medicine in breast cancer.
Ali G Alkhathami, Abdulrahman T Ahmed, Ahmed Hussein, Roopashree R, Prakhar Tomar, Hussein Riyadh Abdul Kareem Al-Hetty, Rajashree Panigrahi, Ashish Singh Chauhan, Fathi Jihad Hammady, Salah Abdulhadi Salih
Published: 202510.1016/j.retram.2025.103561
Abstract
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) represents a significant advancement in breast cancer therapy by enhancing drug delivery and minimizing solvent-related toxicity. Utilizing albumin-mediated transcytosis, nab-paclitaxel achieves…
Preview only. Read the full abstract at the source